1,270
Views
9
CrossRef citations to date
0
Altmetric
Review

A bimodal pattern of the onset of COVID-19 related acute pancreatitis supports both the cytotoxic and immune-related pathogenesis – a systematic review

, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 870-873 | Received 25 Feb 2021, Accepted 20 Apr 2021, Published online: 14 May 2021
 

Abstract

Objectives

To review clinical and laboratory findings in patients with SARS-Cov-2 (COVID-19) related acute pancreatitis.

Methods

This systematic review was based on a database search for articles of COVID-19 related acute pancreatitis in adult patients with confirmed COVID-19 infection that included age, gender, presenting symptoms, the onset of symptoms, laboratory values, imaging findings and exclusion of common causes of pancreatitis.

Results

Altogether 35 articles comprising 37 patients were included. Acute pancreatitis was the first presentation of COVID-19 in 43% of patients, concurrent with general or respiratory symptoms in 14% of patients or delayed after general or pulmonary symptoms by an average of 10 ± 5 d (range, 1 − 19 d) in 43% of patients. Serum amylase and lipase levels were elevated in 87% and 100% of patients. In 50% and 84%, amylase and lipase levels exceeded three-fold the upper normal limit. Pancreatic necrosis was reported in 6% of patients and in 12% of patients, the pancreas appeared normal. Three patients died.

Conclusions

We conclude that the bi-modal pattern of the onset of symptoms supports both the cytotoxic and the immune-related pathogenesis of the pancreatic injury. Acute pancreatitis may be the first symptom of COVID-19 infection. Necrosis of the pancreas is rare.

Disclosure statement

The authors declare that they have no conflict of interest regarding the publication of this work.

Additional information

Funding

This study was supported by the Ministry of Health of the Czech Republic [General University Hospital in Prague – VFN, 00064165] and the Charles University in Prague [Progres Q28/LF1, UNCE 204065].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.